[R01] A Randomized Study of Maternal Donor Derived CMV Cytotoxic T-Lymphocytes (CTLs) and Valganciclovir vs Valganciclovir in Neonates With Moderate/Severe Maternal Acquired CMV Infection
Ente: Food and Drug Administration
Scadenza: 2028-05-31
Importo max: $324,998
Paese: US
Descrizione
Project Summary
Congenital cytomegalovirus (cCMV) infection that is acquired in-utero, although an orphan disease (20-80,000
cases/yr in U.S.) is the most common congenital infection in the U.S. and the leading cause of long-term
neurodevelopmental disabilities. cCMV infection represents 41% of all
Settori: Food and Drug Administration
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.